We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mindfulness Based Stress Reduction in COPD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01058499
Recruitment Status : Completed
First Posted : January 28, 2010
Last Update Posted : March 21, 2016
Sponsor:
Information provided by (Responsible Party):
Roberto P. Benzo, Mayo Clinic

Brief Summary:
The objective of this study is to test the efficacy of a Mindfulness Based Stress Reduction program in COPD on quality of life, dyspnea, daily physical activity and mindfulness during daily life.

Condition or disease Intervention/treatment Phase
Chronic Obstructive Pulmonary Disease COPD Behavioral: Mindfulness Based Stress Reduction Program (MBSR) Phase 1

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Mindfulness Based Stress Reduction in COPD
Study Start Date : February 2010
Primary Completion Date : September 2010
Study Completion Date : December 2010

Arm Intervention/treatment
Experimental: MBSR Behavioral: Mindfulness Based Stress Reduction Program (MBSR)
Traditional eight-week MBSR Program.



Primary Outcome Measures :
  1. We hypothesize that the perception of well being will increase after participants go through the MBSR program for COPD. [ Time Frame: Baseline and at eight weeks ]

Secondary Outcome Measures :
  1. Participants in the MBSR for COPD will have an increase in their physical activity level. [ Time Frame: Baseline and 8 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 99 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  • clinical diagnosis of COPD
  • clinically significant dyspnea, as determined by a score of >=2 on the Medical Research Council of Dyspnea Score questionnaire (0-4).

Exclusion criteria:

  • patients with a high likelihood of not completing the program (active chemical dependency)
  • patients with an inability fo provide good data or to follow commands (neurologic or psychiatric condition).
  • poor motivation or lack of interest in program

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01058499


Locations
United States, Minnesota
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
Investigators
Principal Investigator: Roberto Benzo, MD Mayo Clinic

Responsible Party: Roberto P. Benzo, M.D., Mayo Clinic
ClinicalTrials.gov Identifier: NCT01058499     History of Changes
Other Study ID Numbers: 09-008478
First Posted: January 28, 2010    Key Record Dates
Last Update Posted: March 21, 2016
Last Verified: March 2016

Keywords provided by Roberto P. Benzo, Mayo Clinic:
Chronic Obstructive Pulmonary Disease
COPD

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases